Carta Healthcare Designated as a Certified Software Vendor for the CathPCI Registry

July 1, 2021—Carta Healthcare, a provider of artificial intelligence- (AI-) powered clinical data abstraction technology and services, announced that it is now a certified software vendor for the CathPCI Registry, a component of the National Cardiovascular Data Registry (NCDR).

Carta’s Atlas data abstraction solution uses AI to abstract data from electronic medical records, populating clinical registries with greater efficiency and accuracy than manual abstraction, stated the company.

NCDR is the American College of Cardiology's (ACC) suite of cardiovascular data registries that are used to help hospitals and private practices measure and improve the quality of care they provide.

Carta noted that the registries of the NCDR collect and compile information from vast amounts of patient data to understand diseases and conditions, further research and quality initiatives, and provide insights about patient outcomes. Specifically, the CathPCI Registry assesses the characteristics, treatments, and outcomes of cardiac disease patients who receive diagnostic catheterization and/or percutaneous coronary intervention procedures.

The Atlas AI-assisted technology automates the collection and aggregation of patient data—both structured and unstructured—from multiple secondary sources, driving clinical insights through faster, reliable data collection.

As an NCDR certified software vendor, Atlas will provide end-to-end submission to the CathPCI Registry, including automatic updates of the NCDR data requirements to ensure compliant data submissions.

ACC Chief Innovation Officer John Rumsfeld, MD, commented in Carta's press release, “A key focus for the ACC Innovation Program is artificial intelligence-driven care. We are excited about our collaboration with Carta, to assist hospitals and improve the efficiency of data abstraction. Our collaboration can help hospitals advance patient care and successfully respond to a changing world, while helping the ACC bring its vision of innovation and knowledge that optimizes cardiovascular care and outcomes into reality.”